Effects of Low-Sodium Salt on Death, HF Hospitalization/ Emergency Department Visits and Quality of Life in HF Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorHeart Health Research Center

About this trial

This study aims to investigate whether using a low-sodium substitute salt can help improve outcomes for patients with heart failure. Specifically, it will examine if the low-sodium substitute salt can reduce death rates, hospital readmissions, and emergency visits, as well as improve the quality of life for these patients.

Eligibility criteria

Qualifiers

Aged between 18 and 75 years;

Hospitalized due to heart failure in the past year;

NYHA functional class II-III;

Echocardiographic evidence of LVEF < 40% within the past 6 months;

Disqualifiers

End-stage heart failure;

Hospitalization due to cardiovascular causes within the past month;

Uncorrected hyponatremia (Na < 130 mmol/L);

Dialysis-dependent patients, or eGFR < 20 mL/min/1.73m²;

Trial design

Treatments tested in this trial

  • low-sodium substitute salt

Treatment groups

1,301 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Heart Health Research Center

Lead sponsor

Beijing Anzhen Hospital

Collaborator